Economic TimesFDA Approves New Anti-bacterial Drug to Treat Dermal InfectionsThe Westside StoryChicago-based Durata Therapeutics, Inc. (Nasdaq:DRTX) has announced that the US FDA has approved the sale and distribution of its new antibiotic for the treatment of common bacterial skin infections which are acquired in the hospitals. The antibiotic …FDA Approves New Antibacterial Drug to Treat Skin InfectionsYottaFireFDA nod to Durata drug for acute skin infectionsDelhi Daily NewsNew Drug Dalvance Wins FDA Approval to Treat Skin InfectionsScience World ReportNature World News -Boston.comall 63 news articles …Read Full Story
FDA Approves New Anti-bacterial Drug to Treat Dermal Infections - The Westside Story
Real Estate of Cebu
